These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11523539)

  • 21. Relationship between PPP1R15A gene polymorphism (rs611251) and Epstein-Barr virus-associated tumors.
    Song Y; Liu S; Zhao Z; Zhang Y; Yang Y; Luo B
    Acta Virol; 2017; 61(4):445-452. PubMed ID: 29186961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
    J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burkitt's Lymphoma.
    Rochford R; Moormann AM
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):267-85. PubMed ID: 26424650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
    Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
    Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
    Coghill AE; Wang CP; Verkuijilen SAWM; Yu KJ; Hsu WL; Middeldorp JM; Hildesheim A
    J Med Virol; 2018 Jan; 90(1):191-195. PubMed ID: 28833336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus strain characterisation in South African patients with nasopharyngeal carcinomas.
    Janse van Rensburg E; van Heerden WF; Robson BA; Swart TJ; Engelbrecht S
    Anticancer Res; 2000; 20(3B):1953-7. PubMed ID: 10928133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P; De Matteo E; Merediz A; Preciado MV
    Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus.
    Gutiérrez MI; Ibrahim MM; Dale JK; Greiner TC; Straus SE; Bhatia K
    J Natl Cancer Inst; 2002 Dec; 94(23):1757-63. PubMed ID: 12464647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
    Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community detection in Epstein-Barr virus associated carcinomas and role of tyrosine kinase in etiological mechanisms for oncogenesis.
    Chatterjee S; Sanjeev BS
    Microb Pathog; 2023 Jul; 180():106115. PubMed ID: 37137346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
    de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
    HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence variation of Epstein-Barr virus (EBV) BCRF1 in lymphomas in non-endemic areas of nasopharyngeal carcinoma.
    Han L; Sun L; Zhao Z; Chao Y; Sun Z; Li H; Luo B
    Arch Virol; 2015 Feb; 160(2):441-5. PubMed ID: 25373543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proof for EBV's sustaining role in Burkitt's lymphomas.
    Vereide D; Sugden B
    Semin Cancer Biol; 2009 Dec; 19(6):389-93. PubMed ID: 19628040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus infections and their association with human malignancies: some key questions.
    Griffin BE; Xue SA
    Ann Med; 1998 Jun; 30(3):249-59. PubMed ID: 9677010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.
    Kennedy G; Komano J; Sugden B
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14269-74. PubMed ID: 14603034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus in Hodgkin's disease.
    Chapman AL; Rickinson AB
    Ann Oncol; 1998; 9 Suppl 5():S5-16. PubMed ID: 9926231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epstein-Barr virus].
    Tsurumi T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():582-6. PubMed ID: 12718032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.